Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Kranz

Showing results (1-10 of 115) with videos related to

Pageof 12
Sort By:
Nature Immunology|January 22, 2005
T cell receptor CDRs: starring versus supporting rolesDavid M Kranz
F1000 Biology Reports|October 16, 2010
Two mechanisms that account for major histocompatibility complex restriction of T cellsDavid M Kranz
Proceedings of the National Academy of Sciences of the United States of America|January 25, 2015
Herman N. Eisen: Mentor to manyDavid M Kranz, Yuri Sykulev
F1000Research|October 6, 2016
Recent advances in T-cell engineering for use in immunotherapyPreeti Sharma, David M Kranz
Critical Reviews in Immunology|November 4, 2019
T Cell Receptors for Gene Transfer in Adoptive T Cell TherapyPreeti Sharma, David M Kranz
The Journal of Biological Chemistry|September 26, 2013
The same major histocompatibility complex polymorphism involved in control of HIV influences peptide binding in the mouse H-2Ld systemSamanthi Narayanan, David M Kranz
The Journal of Biological Chemistry|December 13, 2017
Subtle changes at the variable domain interface of the T-cell receptor can strongly increase affinityPreeti Sharma, David M Kranz
Immunity|February 22, 2003
Quantitative analysis of the contribution of TCR/pepMHC affinity and CD8 to T cell activationPhillip D Holler, David M Kranz
Molecular Immunology|March 24, 2004
T cell receptors: affinities, cross-reactivities, and a conformer modelPhillip D Holler, David M Kranz
Frontiers in Immunology|August 24, 2013
Role of T cell receptor affinity in the efficacy and specificity of adoptive T cell therapiesJennifer D Stone, David M Kranz
Pageof 12

Showing results (1-10 of 115) with videos related to

Sort By:
Pageof 12
Nature Immunology|January 22, 2005
T cell receptor CDRs: starring versus supporting rolesDavid M Kranz
F1000 Biology Reports|October 16, 2010
Two mechanisms that account for major histocompatibility complex restriction of T cellsDavid M Kranz
Proceedings of the National Academy of Sciences of the United States of America|January 25, 2015
Herman N. Eisen: Mentor to manyDavid M Kranz, Yuri Sykulev
F1000Research|October 6, 2016
Recent advances in T-cell engineering for use in immunotherapyPreeti Sharma, David M Kranz
Critical Reviews in Immunology|November 4, 2019
T Cell Receptors for Gene Transfer in Adoptive T Cell TherapyPreeti Sharma, David M Kranz
The Journal of Biological Chemistry|September 26, 2013
The same major histocompatibility complex polymorphism involved in control of HIV influences peptide binding in the mouse H-2Ld systemSamanthi Narayanan, David M Kranz
The Journal of Biological Chemistry|December 13, 2017
Subtle changes at the variable domain interface of the T-cell receptor can strongly increase affinityPreeti Sharma, David M Kranz
Immunity|February 22, 2003
Quantitative analysis of the contribution of TCR/pepMHC affinity and CD8 to T cell activationPhillip D Holler, David M Kranz
Molecular Immunology|March 24, 2004
T cell receptors: affinities, cross-reactivities, and a conformer modelPhillip D Holler, David M Kranz
Frontiers in Immunology|August 24, 2013
Role of T cell receptor affinity in the efficacy and specificity of adoptive T cell therapiesJennifer D Stone, David M Kranz
Pageof 12